학력 및 경력
|
충남대학교 의학학사
울산대학교 의학석사 서울아산병원 수련의 서울아산병원 내과 전공의 국군기무사령부 내과 과장 서울아산병원 종양내과 전임의 미국 Northwestern Memorial Hospital, Lurie cancer center 단기연수 現강북삼성병원 혈액종양내과 임상조교수 |
학회 활동
|
[학회활동]
대한임상종양학회 (KACO) 대한암학회 (KCA) 대한항암요법연구회 (KCSG) 미국암학회 (ASCO) 유럽암학회 (ESMO) [수상경력] 제6회 서울아산병원 간센터 심포지엄 우수 구연상 (2016.4.30) |
대표 논문
|
1. Jihoon Kang, Yoosoo Chang, Jiin Ahn, Sukjoong Oh, Dong-Hoe Koo, Yun-Gyoo Lee, Hocheol Shin, Seungho Ryu: Neutrophil-to-lymphocyte ratio and risk of lung cancer mortality in a low-risk population: A cohort study: Int J Cancer 2019;145(12):3267-3275 2. Changhoon Yoo*, Jihoon Kang*, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo: Phase I dose finding study of OPB-111077, a Novel STAT3 Inhibitor, in patients with Advanced Hepatocellular carcinoma: Cancer Res Treat 2019;51(2):510-518 *1st coauthor 3. Jihoon Kang, Jung Yong Hong, Dok Hyun Yoon, Jeong Eun Kim, Kyu-pyo Kim, Shin Kim, Kyoung Min Lee, Jung Sun Park, Ji Sung Lee, and Cheolwon Suh: Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis: Transfusion 2019;59(5):1781-1788 4. Inhwang Hwang*, Jihoon Kang*, Hei Nga Natalie Ip, Jae Ho Jeong, Kyu-pyo Kim, Heung-Moon Chang, Changhoon Yoo, Baek-Yeol Ryoo: Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores: Invest New Drugs 2019;37(3):584-590 *1st coauthor 5. Jihoon Kang*, Inhwang Hwang*, Changhoon Yoo, Kyu-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Seung-Mo Hong, Sang Hyun Shin, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Song Cheol Kim, Baek-Yeol Ryoo: Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis: Invest New Drugs 2018;36(4):732-741 *1st coauthor 6. Jihoon Kang, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Kyoung Min Lee, Jung Sun Park, Chan-Jeoung Park, Won-Ki Min, Eul-Ju Seo, Seongsoo Jang, Cheolwon Suh: Efficacy and survival outcome associated with the use of novel agents and autologous stem cell transplantation in cases of immunoglobulin D multiple myeloma in Korea: Acta Haematologica 2018;139(3):185-192 7. Jihoon Kang, Jung Yong Hong, Cheolwon Suh: Clinical features and survival outcomes for patients with lymphoplasmacytic lymphoma, including non-IgM type, in Korea: a single center experience: Blood Res 2018;53:189-197 8. Jihoon Kang, Shinkyo Yoon, Cheolwon Suh: Relevance of prognostic index with B2- microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era: Blood Res 2017;52(4):276-284 9. Changhoon Yoo*, Jihoon Kang*, Kyu-Pyo Kim, Jae-Lyun Lee, Baek-Yeol Ryoo, Heung-Moon Chang, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Song Cheol Kim: Efficacy and Safety of Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: Improved Efficacy Compared with Gemcitabine-based Regimen: Oncotarget 2017;8(28):46337-46347 *1st coauthor |
기타
-
정보보호관리체계(ISMS) 인증 -
국제정보보호(ISO27001) 인증 -
보건복지부
의료기관 인증병원 -
생명의학연구윤리 국제인증 획득 -
美, 하원 표창장 -
美, 존스홉킨스
연구협약 체결
